Evaluation of mid-term outcomes of pulmonary valve replacement surgery after repair of tetralogy of Fallot
- VernacularTitle:法洛四联症术后肺动脉瓣置换术的中期效果评价
- Author:
Dong ZHAO
1
;
Keming YANG
1
;
Shoujun LI
1
Author Information
1. Department of Cardiac Surgery, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing Union Medical College, Chinese Academy of Medical Sciences, 100037, Beijing, P.R.China
- Publication Type:Journal Article
- Keywords:
Pulmonary valve replacement;
tetralogy of Fallot;
valve failure;
reintervention
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(04):404-408
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate mid-term outcomes of pulmonary valve replacement surgery after repair of tetralogy of Fallot. Methods A total of 73 patients with repaired tetralogy of Fallot who underwent pulmonary valve replacement surgery in our hospital from January 2010 to January 2020 were enrolled, including 42 males and 31 females. The median age was 3.9 (0.2-42.8) years at initial repair and 20.0 (2.0-50.0) years at pulmonary valve replacement. The clinical data of the patients were recorded and analyzed. Results There was no death in postoperative 30 d. The average follow-up time was 35.6±28.5 months, and no death occurred during the follow-up. One patient underwent a second reintervention after initial pulmonary valve replacement. The 1- and 5-year survival rates were both 100.0%, the 1- and 5-year reintervention-free rates were both 100.0%, and the 1- and 5-year valve failure-free rates were 100.0% and 67.1%. There was no significant difference in valve failure-free rates between different age groups (P=0.49) and different type of valve groups (P=0.74). The right (P=0.006) and left (P=0.002) ventricular ejection fractions were significantly improved, and the QRS duration was shortened after pulmonary valve replacement (P=0.006). Conclusion Mid-term outcomes of surgical pulmonary valve replacement were satisfactory in patients with repaired tetralogy of Fallot, while the long-term effects should be further emphasized in clinical practice.
